13 recent scientific breakthroughs
From photos of the infant universe to an energy advancement that could save the planet
Source: yahoo.com
📰 Cath Mummery News
Cath Mummery News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cath Mummery. Real-time updates on events, politics, business and more.
New Alzheimer's drugs bring hope of slowing disease for UK patients | Alzheimer's
Two dementia medicines set for approval in Britain are first to improve patients’ lives directly – but condition must be diagnosed
United Kingdom Eleanor Mackenzie Smith Eli Lilly Graeme Armstrong David Thomas National Institute For Health
Source: theguardian.com
Alnylam Reports Additional Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer's Disease and Cerebral Amyloid Angiopathy -October 25, 2023 at 11:06 am EDT
– Single Doses of ALN-APP Achieve Sustained Pharmacodynamic Activity up to 10 Months After Administration – – Observed Marked Reductions in Aβ42 and Aβ40, Amyloid Fragments Implicated in...
United Kingdom United States Tim Mooney Program Leader At Alnylam Exchange Commission Alnylam Pharmaceuticals
Source: marketscreener.com
Alnylam Reports Additional Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer's Disease and Cerebral Amyloid Angiopathy Seite 1
25.10.2023 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) today announced additional positive interim results for the ongoing single ascending dose portion of the Phase 1 study of ALN-APP, an investigational RNAi therapeutic targeting amyloid precursor protein ... Seite 1
United States Dementia Research Centre University College London Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Clinical Trials
Source: wallstreet-online.de
Alnylam Pharma Reports Additional Positive Interim Phase 1 Results For Alzheimer's Disease Treatment
(RTTNews) - Alnylam Pharmaceuticals, Inc. (ALNY) Wednesday announced additional positive interim results for the ongoing single ascending dose por...
Alnylam Pharmaceuticals Inc University College London Dementia Research Centre Cath Mummery Consultant Neurologist Clinical Trials
Source: businessinsider.com
Promising research finds this common HIV drug might also help beat Alzheimer's
Any treatment for Alzheimer’s is to be welcomed — especially if it’s an expensive drug already in use for another condition. Any treatment for Alzheimer’s is to be welcomed, especially if it’s an expensive drug already in use.
United Kingdom David Rubinsztein United Kingdom National Hospital For Neurology United Kingdom Dementia Research Institute Cambridge University Professor David Rubinsztein
Source: queerty.com
New Alzheimer's drug slows disease by a third
The company Eli Lilly has reported its drug - donanemab - slows the pace of Alzheimer's by about a third.
Source: the-star.co.ke
Drug reduces Alzheimer's symptoms by 35 per cent
A new drug can reduce symptoms of Alzheimers disease by 35 per cent.
City Of United Kingdom Eli Lilly National Hospital For Neurology Cath Mummery Cognitive Disorders Clinic
Source: femalefirst.co.uk
New Alzheimer's drug slows cognitive decline by a third
A new Alzheimer's drug, 'donanemab', was found to clear amyloid plaques from the brains, and slow cognitive decline by about a third.
Source: thenewdaily.com.au
NHS 'not ready' to dish out breakthrough Alzheimer's drug
Top doctors today warned that the NHS is not ready to dish out the medication, made by US-based pharmaceutical giant Eli Lilly, and needs to gear up now in preparation to do so.
Source: dailymail.co.uk